Sviridov
Aleksej Yur'Evich Sviridov, Moskow RU
Patent application number | Description | Published |
---|---|---|
20130316991 | Biologically active supplements and process of its production - The invention relates to dietary and prophylactic biologically active food supplements (BAS), in particular, from raw plant material and methods for their production; it can be used as a food supplement for human and domestic animals to reduce the cholesterol content in blood, stimulation of protein glycosylation and prophylaxis of infectious and cardiovascular diseases. | 11-28-2013 |
Alexander Sviridov, Moscow RU
Patent application number | Description | Published |
---|---|---|
20150112136 | POLARIMETRIC ACCESSORY FOR COLPOSCOPE - A polarization-based colposcopy apparatus includes a polarization exchanging beam splitter pair oriented so that s- and p-polarizations are exchanged. An optical flux from a specimen is directed through the pair, and orthogonal components thereof are alternately or selectively coupled to an array detector. The detected images are processed based on image correlations to reveal specimen structures. | 04-23-2015 |
Alexander P. Sviridov, Moscow RU
Patent application number | Description | Published |
---|---|---|
20120191005 | Diagnostic and Feedback Control for Efficacy and Safety of Laser Application for Tissue Reshaping and Regeneration - The efficacy and safety of laser medical treatments are ensured by performing a combination of measurement techniques to examine tissue properties in order to control characteristics of the laser treatments of cartilaginous tissues. In some aspects, methods of treatment are provided that are capable of taking and providing feedback relating to multiple measurements, including temperature measurements (in particular, radiometry), light scattering, speckle interferometry, optoacoustic measurements, and monitoring tissue electrical characteristics. According to various aspects, feedback is provided during the course of laser treatment of tissue to increase the safety and efficacy of treatment. | 07-26-2012 |
20120191021 | Diagnostic and Feedback Control System for Efficacy and Safety of Laser Application for Tissue Reshaping and Regeneration - The efficacy and safety of laser medical treatments are ensured by performing a combination of measurement techniques to examine tissue properties in order to control characteristics of the laser treatments of cartilaginous tissues. In some aspects, a treatment tool is provided that is capable of taking and providing feedback relating to multiple measurements, including temperature measurements (in particular, radiometry), mechanical measurements, light scattering, speckle interferometry, optoacoustic measurements, and monitoring tissue electrical characteristics. The device is capable of providing feedback during the course of laser treatment of tissue to increase the safety and efficacy of treatment. | 07-26-2012 |
Denis Sviridov, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20140213502 | CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS - Hydrocarbon stapling of apolipoprotein mimetic peptides increases the helicity of the peptides, enhances their ability to promote cholesterol efflux by multiple mechanisms and makes them resistant to proteolysis. Hydrocarbon stapled amphipathic helical peptides are useful in the treatment of cardiovascular diseases and other disorders. | 07-31-2014 |
Dmitri Sviridov, Melbourne AU
Patent application number | Description | Published |
---|---|---|
20110033446 | Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication - The present invention provides novel methods for treating and preventing coronary artery disease in HIV-1-infected individuals by interfering with Nef-mediated effect on ABCA1. The invention further provides novel methods for suppressing HIV infection by stimulating cholesterol efflux from cells by stimulating expression of ABCA1 in HIV-1-infected individuals. These methods take advantage of the finding that Nef, a regulatory protein of HIV-1, (1) diminishes expression of ATP-binding cassette transporter A1 (ABCA1), the main transporter of cholesterol from cells to extracellular acceptors; and (2) impairs cholesterol efflux from HIV-1-infected macrophages leading to cholesterol accumulation and formation of foam cells, which is a characteristic feature of atherosclerosis. | 02-10-2011 |
Evgeny Sviridov, Moscow RU
Patent application number | Description | Published |
---|---|---|
20120034103 | METHOD AND APPARATUS FOR MONITORING OF ESP - A method monitors an ESP with a pump for pumping oil, gas, water or other fluid media, which pump is driven by an electrical motor. Acoustical phenomena of the motor and/or the pump are used as a state variable for pumping the media. The acoustic phenomena are measured as electrical signals and the electrical signals are discriminated in respect to the pumped media. In the corresponding apparatus for monitoring of ESP, with pump section(s) for pumping a mixture of oil, gas and water, which is driven by a motor section(s), whereby at least one acoustic sensor is placed near the ESP. | 02-09-2012 |
Evgeny Mikhailovich Sviridov, Moscow RU
Patent application number | Description | Published |
---|---|---|
20110027110 | OIL FILTER FOR DOWNHOLE MOTOR - A method of controlling operation of an ESP, comprising determining at least one operating speed (rpm) at which the ESP experiences unacceptable levels of lateral vibrations; and applying a periodic modulation to the operating speed when operating the pump at the determined speed to damp the lateral vibrations. | 02-03-2011 |
20110097223 | OIL FILTER FOR DOWNHOLE MOTOR - An oil filter for use in an electric motor forming part of a downhole device such as an ESP, comprising a two-part filter including a first part formed from a porous material which acts to filter solid particulate material from the motor oil, and a second part comprising a sorbent for removing aqueous liquids from the motor oil. | 04-28-2011 |
20120001506 | COMMUTATION SYSTEM FOR A DC MOTOR - A commutation system for a DC motor having a stator including a plurality of windings and a permanent magnet assembly, the assembly comprising: | 01-05-2012 |
Evgeny Mikhaylovich Sviridov, Moscow RU
Patent application number | Description | Published |
---|---|---|
20130058777 | SUBMERSIBLE PUMP STAGE - A submersible pump stage comprises an impeller comprising a first front top disc and a first rear top disc, first blades located between the front and the rear top discs, a bushing and a diffuser comprising a second front top disc and a second rear top disc, second blades located between the second front and second rear top discs. The second rear top disc has through holes passing in end surfaces and located circumferentially. A number of the through holes is selected at least equal to a number of interblade channels. The holes are made so as to provide an overflow of a liquid from a front pocket of this stage of the submersible pump into each interblade channel of a preceding stage diffuser. | 03-07-2013 |
Mikhail V. Sviridov, Novosibirsk RU
Patent application number | Description | Published |
---|---|---|
20150134256 | LATE TIME ROTATION PROCESSING OF MULTI-COMPONENT TRANSIENT EM DATA FOR FORMATION DIP AND AZIMUTH - A system and method to determine a dip angle and an azimuth angle of a formation are described. The system includes a transmitter disposed in a borehole to change a transmitted current to induce a current in an earth formation, and a receiver disposed in the borehole, spaced apart from the transmitter, to receive transient electromagnetic signals. The system also includes a processor to extract multi-time focusing (MTF) responses from the transient electromagnetic signals, determine a relative dip angle and a rotation of a tool comprising the transmitter and receiver based on the MTF responses, and estimate the dip angle and the azimuth angle of the formation based on the relative dip angle and the rotation of the tool. | 05-14-2015 |
Sergey Sviridov, Moscow RU
Patent application number | Description | Published |
---|---|---|
20080207635 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders - The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use. | 08-28-2008 |
20110136824 | UROTENSIN II RECEPTOR ANTAGONISTS - The invention is directed to Urotensin II antagonists. More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating Urotensin-II mediated disorders. Pharmaceutical and veterinary compositions and methods of treating cardiovascular disorders and various other disease states or conditions using compounds of the invention are also described. | 06-09-2011 |
20110305661 | Carbazole Compounds and Therapeutic Uses of the Compounds - Compounds of the general structural formula (I) and (II) and use of the compounds and salts and hydrates thereof, as therapeutic agents are disclosed. Treatable diseases and conditions include cancers, inflammatory diseases and conditions, and immunodeficiency diseases. | 12-15-2011 |
20120214817 | UROTENSIN II RECEPTOR ANTAGONISTS - The invention is directed to Urotensin II antagonists. More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating Urotensin-II mediated disorders. Pharmaceutical and veterinary compositions and methods of treating cardiovascular disorders and various other disease states or conditions using compounds of the invention are also described. | 08-23-2012 |
20140303224 | CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS - Compounds of the general structural formula (I) and (II) and use of the compounds and salts and hydrates thereof, as therapeutic agents are disclosed. Treatable diseases and conditions include cancers, inflammatory diseases and conditions, and immunodeficiency diseases. (I), (II). | 10-09-2014 |
Serguei Sviridov US
Patent application number | Description | Published |
---|---|---|
20100130487 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds of formula (I): | 05-27-2010 |
20110251224 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds of formula (I): | 10-13-2011 |
20120122909 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds of formula (I): | 05-17-2012 |
Serguei V. Sviridov, Burnaby CA
Patent application number | Description | Published |
---|---|---|
20110178126 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS - Pharmaceutical compositions and compounds are provided. The compounds of the invention have use as therapeutic agents, e.g., they demonstrate anti-proliferative, anti-inflammatory, anti-angiogenic, anti-migration activities. In one embodiment of the invention, formulations of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical formulations are useful in the treatment of, e.g., anti-inflammatory, renal, and hyperproliferative disorders. The compounds of the invention are pyrazolylbenzothiazole derivatives of the following formula (1) | 07-21-2011 |
20110237783 | HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS - Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines. | 09-29-2011 |
20130237572 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS - Topical formulations and method of using the same are provided. The topical formulation comprises a pyrazolylbenzothiazole derivative of the following formula (1) | 09-12-2013 |
20140107125 | HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS - Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines. | 04-17-2014 |
20140350009 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS - Topical formulations and method of using the same are provided. The topical formulation comprises a pyrazolylbenzothiazole derivative of the following formula (1) | 11-27-2014 |